Approval · Notice of Compliance 12681 · 2011
ZYCLARA: Notice of Compliance 12681
Issued October 5, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12681
- Date
- October 5, 2011
- Company
- Graceway PharmaceuticalsLondon, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Dosage and ADministration and clinical Trials Sections of the PRoduct onograph
- Therapeutic class
- Immune Response Modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZYCLARA | Not yet assigned | — |
Medicinal ingredients
- IMIQUIMOD 3.75 PER